Literature DB >> 12052525

Expression of alpha-synuclein, the precursor of non-amyloid beta component of Alzheimer's disease amyloid, in human cerebral blood vessels.

Wakako Tamo1, Tadaatsu Imaizumi, Kunikazu Tanji, Hidemi Yoshida, Fumiaki Mori, Makoto Yoshimoto, Hitoshi Takahashi, Ikuo Fukuda, Koichi Wakabayashi, Kei Satoh.   

Abstract

The non-amyloid beta component of Alzheimer's disease amyloid (NAC) is detected in cerebral amyloid angiopathy; and the precursor of NAC is now known to be identical to alpha-synuclein (alpha-S), a major component of Lewy bodies in Parkinson's disease. We studied if cerebral vascular cells express alpha-S. Immunohistochemical studies of human cerebral tissues from control and cerebral amyloid angiopathy patients revealed the expression of alpha-S in vascular endothelial and smooth muscle cells. Then we studied the expression of alpha-S in vitro using cultures of vascular cells. Cultures of human umbilical vein endothelial cells and umbilical artery smooth muscle cells were found to constitutively express alpha-S messenger RNA and protein. alpha-S is normally expressed in vascular cells and may play some physiological role in the vascular wall.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052525     DOI: 10.1016/s0304-3940(02)00297-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

1.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

2.  Reciprocal induction between α-synuclein and β-amyloid in adult rat neurons.

Authors:  Shohreh Majd; Fariba Chegini; Tim Chataway; Xin-Fu Zhou; Weiping Gai
Journal:  Neurotox Res       Date:  2012-05-19       Impact factor: 3.911

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

Review 4.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

5.  Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells.

Authors:  Kwang Soo Kim; Ji-Young Park; Ilo Jou; Sang Myun Park
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

Review 6.  Constipation in Parkinson's Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle?

Authors:  Amol Sharma; Julie Kurek; John C Morgan; Chandramohan Wakade; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2018-01-19

7.  Genetic variation in the alpha synuclein gene (SNCA) is associated with BOLD response to alcohol cues.

Authors:  Claire E Wilcox; Eric D Claus; Sara K Blaine; Marilee Morgan; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

8.  The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response.

Authors:  Mikhail Y Golovko; Gwendolyn Barceló-Coblijn; Paula I Castagnet; Susan Austin; Colin K Combs; Eric J Murphy
Journal:  Mol Cell Biochem       Date:  2008-12-31       Impact factor: 3.396

Review 9.  Biological fluid biomarkers in neurodegenerative parkinsonism.

Authors:  Michael Eller; David R Williams
Journal:  Nat Rev Neurol       Date:  2009-09-01       Impact factor: 42.937

Review 10.  Respiratory Function and Dysfunction in Parkinson-Type Neurodegeneration.

Authors:  M Pokusa; D Hajduchova; T Buday; A Kralova Trancikova
Journal:  Physiol Res       Date:  2020-03-27       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.